Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected

Patil Aarti; Dadewad swapnali; Mansi Patilghote; Renuka R. Deshpande

Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected

Authors: Patil Aarti, Dadewad swapnali, Mansi Patilghote, Renuka R. Deshpande

Unique Paper ID: 149466
Volume: 6
Issue: 12
PageNo: 465-469

Keywords: COVID-19 influence virus

Abstract:
Acute viral respiratory infections (AVRI) are a leading cause of morbidity and mortality among all age groups globally. Except for Influenza virus and Respiratory Syncytial virus, mostly viral aetiology of AVRI remains undiagnosed. Lately, human coronaviruses (HCoVs) have emerged as an important aetiology of AVRI. A laboratory based retrospective cross sectional study was conducted in which respiratory samples (throat swabs) of patients (n Â¼ 864), with Influenza negative SARI, of all age groups between Jan 2011â€“Dec 2012 were tested for HCoVs including MERS-CoV using Conventional and real time PCR assays. The prevalence of HCoV among SARI cases was 1.04% (9/864) [95% CI: 0.36â€“1.72]. Of these four (44.44%) were identified as HCoV OC43, three (33.33%) as HCoV NL63 and two (22.22%) as HCoV 229E. No HCoV HKU1 was detected. The samples were also negative for SARS-CoV and MERS-CoV. The results of this study documents low prevalence of human corona viruses in SARI cases in south western India and the absence of highly pathogenic human coronavi-ruses. As the study included only SARI cases the prevalence reported could be an under estimate when it is extrapolated to community.

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 6
Issue: 12
PageNo: 465-469

Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected

Available:https://ijirt.org/Article?manuscript=149466

11 Jan, 2022

EVALUATION OF MARKETED EFFERVESCENT TABLETS

13 Oct, 2021

Bacterial Biofilm Inhibitor

02 Aug, 2021

The risk of death caused by the use of norepinephrine-resistant hypotension in the condition of septic shock in a patient

02 Aug, 2021

COMPUTER AIDED DRUG DESIGN (CADD)

29 Jul, 2021

Impact : Of Second Wave Covid-19 In world

29 Jul, 2021

The use of milrinone for curing a chronic heart failure

26 Jul, 2021

Leprosy Disease review

20 Jul, 2021

Transdermal Drug Delivery System

13 Jul, 2021

IBUPROFEN: AN OVERVIEW

13 Jul, 2021

CHEMOTHERAPY FOR BREAST CANCER

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry